Sugi Holdings Co Ltd - Stock Quote SGIPF
Morningstar's Sugi Holdings Co Ltd Stock Analysis
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible for overseeing the methodology that supports the quantitative fair value. As an employee of Morningstar, Inc., Mr. Davidson is guided by Morningstar, Inc.'s Code of Ethics and Personal Securities Trading Policy in carrying out his responsibilities. For information regarding Conflicts of Interests, click here .
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Sugi Holdings Co Ltd's Company Profile
Sugi Holdings Co Ltd generates revenue through pharmaceutical care in Japan. The company's drug stores sell prescription and generic drugs along with general merchandise including premium and discount groceries, discount cosmetics, pet supplies, and health supplements that are designed for self-medication. Sugi Holdings also provides disease prevention and drug delivery services. The company's Cedar Pharmacy group operates regional drugstores designed for providing health consultation. Sugi Holdings also supports regional healthcare facilities and provides at-home nursing services.